EMILY GALJOUR: Open Payments
NPI 1497459374 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,408 in 75 payments from 19 companies in 2025. Trend: 2023 $515 · 2024 $733 · 2025 $2,408
Food & beverage: $1,884Consulting: $506Education: $17
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 3 | $569 |
| AstraZeneca Pharmaceuticals LP | 8 | $263 |
| AOP Health US, LLC | 1 | $262 |
| GENZYME CORPORATION | 15 | $199 |
| Insmed, Inc. | 8 | $196 |
| Verona Pharma, Inc. | 9 | $184 |
| Regeneron Healthcare Solutions, Inc. | 10 | $177 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $173 |
| Actelion Pharmaceuticals US, Inc. | 2 | $69 |
| Merck Sharp & Dohme LLC | 2 | $62 |
Products named: DUPIXENT, Rapiblyk, Ohtuvayre, Arikayce, FASENRA, UPTRAVI, WINREVAIR, Tyvaso.
Industry payments across LA — which companies pay providers there.
